Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

BeyondMD vs Maven Clinic

BeyondMD
Graded #176

Higher grade

vs+8.799999999999997
Maven Clinic
Graded #383

Lower grade

The verdict

BeyondMD takes it — 66.8/100 to 58/100.

BeyondMD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Telehealth clinic offering competitively priced compounded semaglutide and tirzepatide.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueBeyondMD +31
76
45
Dose & formulationBeyondMD +11
64
53
Clinical oversightMaven Clinic +3
74
77
Labs & monitoringEven
53
53
FulfillmentMaven Clinic +5
65
70
Contract termsEven
55
55
BeyondMD · left barMaven Clinic · right bar

The numbers

MetricBeyondMDMaven Clinic
WeighScore66.8/10058/100
GradeCC
Scorecard rank#176#383
Semaglutide$139/mo (starting dose, compounded)Not disclosed
Tirzepatide$209/mo (starting dose, compounded)Not disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
BeyondMD

Graded #176 · C

Strengths

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details
Maven Clinic

Graded #383 · C

Strengths

  • Dedicated GLP-1 Care program with brand-name (FDA-approved) GLP-1 prescriptions
  • On-demand visits with metabolic and hormone-health specialists, plus nutrition and strength support
  • Integrated with broader women's, hormone, and family health care
  • LegitScript-verified; trusted by 2,300+ employers
  • Available as both an employer health benefit and a consumer self-pay option

Where it loses points

  • Pricing is not published on the public site
  • Primarily distributed through employers and health plans — direct access can depend on your plan
  • US state availability for GLP-1 is not specified publicly
  • Brand-name only — no lower-cost compounded option

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard